[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356229-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-356229-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","harnessing-ubiquitin-proteasome-system-related-genes-to-identify-subtypes-of-bladder-cancer-and-reveal-immune-landscape","Harnessing Ubiquitin-Proteasome System-Related Genes to Identify Subtypes of Bladder Cancer and Reveal Immune Landscape","","The ubiquitin-proteasome system (UPS) is linked to cancer growth and metastasis, yet its role in bladder cancer (BLCA) remains insufficiently characterized. Survival-associated UPS-related genes were first screened using univariate Cox regression. Based on their expression patterns, BLCA patients were clustered into three groups with distinct overall survival outcomes and then merged into two principal clusters for further analysis. Differential genes mapped mainly to calcium and cytokine-cytokine receptor pathways. Immune profiling indicated immunosuppressive infiltration and checkpoint gene upregulation in one cluster, along with higher TIDE scores and greater somatic mutation burden, while candidate drugs were suggested for each cluster. The findings support clinical treatment stratification for BLCA.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/harnessing-ubiquitin-proteasome-system-related-genes-to-identify-subtypes-of-bladder-cancer-and-reveal-immune-landscape/356229/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/harnessing-ubiquitin-proteasome-system-related-genes-to-identify-subtypes-of-bladder-cancer-and-reveal-immune-landscape/356229.png","ImageObject",300,407,{"name":42,"@type":43},"Jiven","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How were UPS-related genes and patient subtypes identified in the study?","Question",{"text":63,"@type":64},"Survival-associated UPS-related genes were screened using univariate Cox regression. Patients were then grouped using unsupervised clustering based on expression of those genes, forming three clusters that were further consolidated for downstream analysis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What immune features distinguished the two main clusters?",{"text":68,"@type":64},"One cluster showed strong infiltration of immunosuppressive cells, including M2 macrophages and Tregs, along with elevated immune checkpoint gene expression (e.g., BTLA and CTLA4) and a higher TIDE score.",{"name":70,"@type":61,"acceptedAnswer":71},"How did the clusters differ in somatic mutations and drug candidates?",{"text":72,"@type":64},"Somatic mutation rates were higher in the immune-suppressive cluster. Candidate therapeutics were predicted for each cluster, with different drug sets proposed as potentially more suitable depending on the cluster.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356229,1790154606,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","Harnessing Ubiquitin-Proteasome System-Related Genes to Identify Subtypes of Bladder Cancer and Reveal Immune Landscape  \nAmerican Journal of Men’s Health January-February 1–11 © The Author(s) 2026  \nArticle reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/15579883251410519](DOI: 10.1177/15579883251410519)[ ](DOI: 10.1177/15579883251410519)[journals.sagepub.com/home/jmh](journals.sagepub.com/home/jmh)  \nGuanyun Shi 1, Xianfei Zhou2, Fan Yang2, and Tianxing Wang3  \nAbstract  \nThe ubiquitin-proteasome system (UPS) is intricately linked to the growth and metastasis of numerous types of cancer. However, current analysis on the function and impact of UPS in bladder cancer (BLCA) is still sparse. First, univariate Cox regression analysis was applied to screen survival-associated UPS-related genes (UPSGs). Then, based on the expression of survival-related UPSGs, BLCA patients were divided into three clusters through unsupervised cluster analysis, and the overall survival rate of Cluster 1 and Cluster 3 was higher than that of Cluster 2, but there was no survival difference between Cluster 1 and Cluster 3. Therefore, Cluster 1 + Cluster 3 (Cluster A) and Cluster 2 (Cluster B) were selected for subsequent analysis. The differentially expressed genes of the two clusters were predominantly enriched in signaling pathways such as the Calcium signaling pathway and Cytokine-cytokine receptor interaction. An immune microenvironment analysis revealed that Cluster B patients were characterized by highly infiltrated immunosuppressive cells (M2 macrophages and Tregs) as well as high expression of immune checkpoint genes (such as BTLA and CTLA4). Furthermore, Cluster B exhibited a higher TIDE score. Somatic mutations demonstrated that the mutation rate of Cluster B was higher than that of Cluster A. In addition, candidate drugs for two clusters of patients were predicted, with Lapatinib, Doramapimod, and SCH772984 may be potential drugs for Cluster A patients. Luminespib, Staurosporine, and Dasatinib may be more suitable for Cluster B patients. The study provides a reference for guiding the clinical treatment of BLCA patients.  \nKeywords  \nbladder cancer, ubiquitin-proteasome system, molecular subtype, immunity, features  \nReceived: December 26, 2024; revised: March 27, 2025; accepted: December 8, 2025  \nIntroduction  \nBladder cancer (BLCA) ranks among the 10 most prevalent cancers in the world. According to statistics, in 2022, there will be about 613,000 new BLCA cases and 220,000 deaths worldwide (Bray et al., 2024) . BLCA is a heterogeneous disease with two subtypes: non-muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC), where NMIBC accounts for approximately 75% of BLCA cases (Richters et al., 2020) . Despite advancements in radical cystectomy and platinum-based neoadjuvant therapy, the prognosis for BLCA patients remains suboptimal, with higher rates of recurrence and metastasis (Wang et al., 2022) . The recurrence  \nrate of NMIBC patients within 5 years after surgery exceeds 50%, and 10% to 30% of patients may progress to MIBC (Kamat et al., 2016) . MIBC, due to strong  \n1 Department of Urology, Taizhou Municipal Hospital, Taizhou, China 2Department of General Surgery, Taizhou Municipal Hospital, Taizhou, China  \n3Department of General Surgery, Taizhou Boai Hospital, Taizhou, China  \nCorresponding Author:  \nTianxing Wang, Department of General Surgery, Taizhou Boai Hospital, No. 609 Shanghai South Street, Luqiao District, Taizhou 318050, Zhejiang, China.  \n[Email: wangtxx112@163.com](Email: wangtxx112@163.com)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License ([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)) which permits non-commercial use,  \nreproduction and distribution ","cbCaikESsaJ5OCKw","https://ap.wps.com/l/cbCaikESsaJ5OCKw","pdf",3666992,11,"English","# Abstract\n# Introduction\n## Bladder cancer background and clinical challenges\n## UPS biology and relevance to cancer","[{\"question\":\"How were UPS-related genes and patient subtypes identified in the study?\",\"answer\":\"Survival-associated UPS-related genes were screened using univariate Cox regression. Patients were then grouped using unsupervised clustering based on expression of those genes, forming three clusters that were further consolidated for downstream analysis.\"},{\"question\":\"What immune features distinguished the two main clusters?\",\"answer\":\"One cluster showed strong infiltration of immunosuppressive cells, including M2 macrophages and Tregs, along with elevated immune checkpoint gene expression (e.g., BTLA and CTLA4) and a higher TIDE score.\"},{\"question\":\"How did the clusters differ in somatic mutations and drug candidates?\",\"answer\":\"Somatic mutation rates were higher in the immune-suppressive cluster. Candidate therapeutics were predicted for each cluster, with different drug sets proposed as potentially more suitable depending on the cluster.\"}]","Harnessing Ubiquitin-Proteasome System-Related Genes to Identify Subtypes of Bladder Cancer and Reveal Immune Landscape | PDF",1790124190,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f4b00413098d4e02f8f7cc52570e9b6f.webp",983,1315,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cefa9dc9e0f8852e01d7f4dbfd318776.webp",982,1314,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/278f1bb3654c288a9a41145312a61ed2.webp",981,1312,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/16ad5bd7da9890976606505257f97d96.webp",980,1311]